-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Career Development Lunch- Room 1

PhD Trainee
Program: Trainee Activities and Services
Saturday, December 5, 2015: 11:15 AM-12:15 PM
Regency Ballroom P (Hyatt Regency Orlando)
Chair:
Alison Loren, MD, MS, Abramson Cancer Center of the University of Pennsylvania

Disclosures:
Loren: Merck: Research Funding .
These sessions will provide an intimate venue for trainees to meet with leaders in hematology to discuss professional development questions. ASH has invited a diverse group of more than 30 distinguished researchers and physicians to participate, representing the wide array of practice areas within hematology. Faculty will be available to discuss careers in basic, clinical, and translational research. There will also be representatives present to discuss PhD careers, careers in industry settings, and careers in private and clinical practice. This event is open only to Associate members; Medical Student, Graduate Student, and Resident members; and non-members in training wearing blue trainee meeting badges.

A boxed lunch will be provided. Space is available on a first-come, first-served basis. As seating is limited, attendees are strongly encouraged to arrive early. No additional participants will be allowed in the rooms once these sessions are filled.

David Avigan, MD

Beth Israel Deaconess Medical Center, Boston, MA

Richard M. Stone, MD

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Kenneth A. Bauer, MD

Beth Israel Deaconess Medical Center, Boston, MA

Margaret V Ragni

University of Pittsburgh and Hemophilia Center of Western Pennsylvania, Pittsburgh, PA

Ross L. Levine, MD

Memorial Sloan Kettering Cancer Center, New York, NY

Pavan Reddy, MD

Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI

Benjamin Kim, MD, MPhil

Genentech, South San Francisco, CA

William E. Hobbs, MD/PhD

Hematology, Biogen, Cambridge, MA

Ann T Farrell, MD

Center for Drug Evaluation and Research, FDA, Silver Spring, MD

Wyndham H. Wilson, MD, PhD

National Cancer Institute, Bethesda, MD

Mitchell Weiss, MD, PhD

Rm. 316B, Abramson Rsch. Ctr., Children's Hosp. of Philadelphia, Philadelphia, PA

William L. Carroll, MD

Pediatrics, NYU Langone Medical Center, New York, NY

Ellinor I.B. Peerschke, PhD

Memorial Sloan Kettering Cancer Center, New York, NY

Margaret A Goodell, PhD

Pediatrics, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX

Robb Friedman, MD

Beth Israel Deaconess Medical Center, Boston, MA

Alexander I. Spira, MD, PhD

Virginia Cancer Specialists, Fairfax, VA

Jason Gotlib, MD

School of Medicine/ Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA

Jennifer C. Kesselheim, MD, MEd

Dana-Farber Cancer Institute, Boston, MA

Gary J Schiller, MD

University of California, Los Angeles, CA

Marc Zumberg, MD

Division of Hem./Onc., Univ. of Florida, Gainesville, FL